Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis - Tandem mass spectrometry with successive multiple ionic - Polymer layer coated capillary

Talanta. 2018 Jan 1:176:69-76. doi: 10.1016/j.talanta.2017.08.010. Epub 2017 Aug 3.

Abstract

A novel non-aqueous capillary electrophoresis - tandem mass spectrometry method for the simultaneous separation, identification and quantification of nine designer benzodiazepines (bentazepam, etizolam, deschloroetizolam, diclazepam, flubromazepam, flubromazolam, nimetazepam, phenazepam, and pyrazolam) was developed. A non-aqueous running electrolyte consisting of 25mM ammonium acetate with 100mM trifluoroacetic acid in acetonitrile was used. The separation was carried out using a semipermanent coated capillary (successive multiple ionic-polymer coating) with a strong anodic electroosmotic flow at a negative separation voltage within twelve minutes. Electrospray ionization with a triple quadrupole mass spectrometry was utilized for the identification and quantification of selected designer benzodiazepines in a positive ionization mode. The developed method was validated and applied on the analysis of spiked serum sample following a simple liquid-liquid extraction. The LODs of the designer benzodiazepines were between 1.5 and 15.0ngmL-1.

Keywords: Benzodiazepine; Capillary electrophoresis; Designer drug; Mass spectrometry; Nonaqueous electrolyte; Toxicological analysis.

MeSH terms

  • Benzodiazepines / blood*
  • Designer Drugs / analysis*
  • Electrophoresis, Capillary
  • Hexadimethrine Bromide / chemistry
  • Humans
  • Limit of Detection
  • Liquid-Liquid Extraction
  • Spectrometry, Mass, Electrospray Ionization
  • Tandem Mass Spectrometry

Substances

  • Designer Drugs
  • Benzodiazepines
  • Hexadimethrine Bromide